Publication Year

Grant RL, Morrill D, Manis D, Tachovsky A, Haws LC. The Texas combustion project: Review of trial burn/risk burn plans and reports. International Conference on Incineration and Thermal Treatment Technologies, Portland, OR, May 2000.

Finley BL, Proctor DM, Harris MA, Fowler JF. 2000. Letter to the editor: Patch testing for chromium sensitivity. American J Contact Derm 11(2)123-125; doi:  10.1053/ac.2000.6339.

Albrecht B, Collins ND, Burniston MT, Nisbet JW, Ratner L, Green PL, Lairmore MD. 2000. Human T-lymphotropic virus type 1 open reading frame I p12I is required for efficient viral infectivity in primary lymphocytes. J Virol 74(21):9828–9835; doi: 10.1128/jvi.74.21.9828-9835.2000. PMID: 11024109.

Shipp AM, Gentry PR, Lawrence G, Van Landingham C, Covington T, Clewell HJ, Gribben K, Crump K. 2000. Determination of a site-specific reference dose for methylmercury for fish-eating populations. Toxicol Ind Health 16(9-10):335–438.

Tachovsky JA, Haws LC, Hofelt CS, McCoy JT. 2000. Risk assessment implementation in Texas. International Conference on Incineration and Thermal Treatment Technologies, Portland, OR, May 2000.

Smith DM, Grasty RC, Theodosiou NA, Tabin CJ, Nascone-Yoder NM.  2000. Evolutionary relationships between the amphibian, avian, and mammalian stomachs. Evolut Develop 2(6):348-59; doi: 10.1046/j.1525-142x.2000.00076.x.

Mcnamara JF, Lombardo H, Pillai SK, Jensen I, Albericio F, Kates SK. 2000. An efficient solid-phase strategy for the construction of chemokines. J Pept Sci 6(10):512–518; doi: 10.1002/1099-1387(200010)6:10<512::AID-PSC269>3.0.CO;2-A.

Newbound GC, O’Rourke JP, Collins ND, Andrews JM, DeWille J, Lairmore MD. 2000. Repression of tax-mediated human T-lymphotropic virus type 1 transcription by inducible cAMP early repressor (ICER) protein in peripheral blood mononuclear cells. J Med Virol 62(2):286–292; doi: 10.1002/1096-9071(200010)62:2<286::AID-JMV22>3.0.CO;2-Y.  PMID: 11002260.

Andersen ME, Sarangapani R, Gentry PR, Clewell HJ, Covington TR, Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol Sci 57:312–325.

Thompson CM, Capdevila JH, Strobel HW. 2000. Recombinant P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exper Ther 294(3):1120–1130; doi: 10.1016/S0022-3565(24)39180-3.

Urban JD, Mailman RB. Functional selectivity as a mechanism of action for newer atypical antipsychotic drugs. Presented at Merck, West Point, PA, 2005.

Kelsh MA, Kheifets LI, Smith RW. 2000. The impact of work environment, utility and sampling design on occupational exposure summaries. AIHA J 61(2):174–182; doi: 10.1080/15298660008984526.

Katona MA, Long TF, Kirman CR, Gargas ML, Rish WR. Derivation of a cancer potency factor and dermal absorption factor for benzo(a)pyrene. Toxicologist 54, Abstract 873. Presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.

Thomas MJ, Robison TW, Forman HJ. 2000. Assessment of tissue injury from reactive oxygen metabolites. In: Chronic Lung Disease in Early Infancy. R.D. Bland and J.J. Coalson, eds. Marcel Dekker, Inc., New York. pp. 779-792.

Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM, Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271(1):250–256; doi: 10.1006/bbrc.2000.2608.

Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM, Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31(2):190–199; 10.1006/rtph.1999.1360.

Clewell HJ III, Gentry PR, Allen BC, Covington TR, Gearhart JM. 2000. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305; doi: 10.1289/ehp.00108s2283.

Gentry R, Clewell H, Covington T, Wilson J. Investigation of the impact of benchmark and PBPK modeling on the derivation of MRLs. Poster presented at Society of Toxicology 39th Annual Meeting, Philadelphia, PA, March 2000.

Morgan RW, Kelsh MA, Zhao K, Exuzides KA, Heringer S, Negrete W. 2000. Radiofrequency exposure and mortality from cancers of the brain and lymphatic/hematopoietic system. Epidemiol 11(2):118–127; doi: 10.1097/00001648-200003000-00007. PMID: 11021607.

Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA. 2000. A pooled analysis of magnetic fields, wire codes and childhood leukemia. Epidemiol 227(2):294–306.